Assuming that these increases may reflect the vigorous total exosome production from aggressive cancer cells as confirmed in previous studies (10), we adopted ACTB, which had a greater difference, as one of the candidate biomarker PEX mRNAs, and used GAPDH as the reference gene. This evidence concerns the gene ACTB and cancer.